|1.||Chen, Jing: 3 articles (05/2015 - 11/2013)|
|2.||Chen, Qiang: 3 articles (08/2013 - 06/2009)|
|3.||Li, Lanfang: 2 articles (12/2015 - 09/2012)|
|4.||Li, Liang: 2 articles (10/2015 - 08/2015)|
|5.||Petersen, Robert B: 2 articles (07/2015 - 02/2014)|
|6.||Chen, Hong: 2 articles (07/2015 - 02/2014)|
|7.||Peng, Anlin: 2 articles (07/2015 - 02/2014)|
|8.||Huang, Kun: 2 articles (07/2015 - 02/2014)|
|9.||Zheng, Ling: 2 articles (07/2015 - 02/2014)|
|10.||Bai, Bo: 2 articles (05/2015 - 01/2015)|
|1.||Hypertension (High Blood Pressure)
05/01/2015 - "The purpose of the present study was to determine whether apelin-13 (AP-13) is involved in the regulation of cardiovascular responses to acute stress in spontaneous hypertension. "
09/01/2014 - "Apelin-13 and APJ in the PVN contribute to hypertension via sympathetic activation and AVP release in SHR. "
09/01/2013 - "These results indicate that apelin-13 might pass through ADMA-damaged endothelium and act on VSMCs to increase MLC phosphorylation, thus contributing to vasoconstriction and exacerbating hypertension. "
09/01/2013 - "Apelin-13 deteriorates hypertension in rats after damage of the vascular endothelium by ADMA."
09/01/2014 - "Apelin-13 and APJ in paraventricular nucleus contribute to hypertension via sympathetic activation and vasopressin release in spontaneously hypertensive rats."
01/01/2014 - "Treatment using apelin-13 and AQP modulators might represent novel treatment strategies against obesity and its related complications."
01/01/2014 - "The aim of this study was to determine how Ramadan fasting (RF) affected the recently described new obesity indices [visceral adiposity index (VAI), waist circumference to height ratio (WHtR), body adiposity index (BAI)], and serum concentration of apelin-13 (RF) in healthy adult men. "
01/01/2014 - "Effect of Ramadan fasting on serum concentration of apelin-13 and new obesity indices in healthy adult men."
01/01/2013 - "Preferential apelin-13 production by the proprotein convertase PCSK3 is implicated in obesity."
12/01/2015 - "The aim this study was to clarify whether apelin-13 promotes hypertrophy in H9c2 rat cardiomyocytes and to investigate its underlying mechanism. "
09/01/2012 - "Furthermore, treatment with apelin-13 promoted myocardial angiogenesis and attenuated cardiac fibrosis and hypertrophy together with a significant improvement of cardiac function at 14 days post-MI. "
12/01/2015 - "These results suggested that apelin-13 promotes H9c2 rat cardiomyocyte hypertrophy via PI3K-Akt-ERK1/2-p70S6K and PI3K-induced autophagy. "
12/01/2015 - "Apelin-13 promotes cardiomyocyte hypertrophy via PI3K-Akt-ERK1/2-p70S6K and PI3K-induced autophagy."
02/01/2014 - "Apelin-13 treatment decreased diabetes-induced glomerular filtration rate, proteinuria, glomerular hypertrophy, mesangial expansion and renal inflammation. "
06/01/2011 - "We studied whether apelin-13 is cardioprotective against ischemia/reperfusion injury if given as either a pre- or postconditioning mimetic and whether the improved postischemic mechanical recovery induced by apelin-13 depends only on the reduced infarct size or also on a recovery of function of the viable myocardium. "
10/12/2015 - "Apelin-13 protects the heart against ischemia-reperfusion injury through the RISK-GSK-3β-mPTP pathway."
05/07/2014 - "Apelin-13 protects the brain against ischemia/reperfusion injury through activating PI3K/Akt and ERK1/2 signaling pathways."
10/01/2011 - "Apelin-13 protects the heart against ischemia-reperfusion injury through inhibition of ER-dependent apoptotic pathways in a time-dependent fashion."
11/01/2007 - "Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury."
01/01/2012 - "Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure."
09/01/2014 - "It is known that apelin has definite protective effects on various cardiovascular diseases; however, the mechanism through which hypertension with heart failure (H-HF) is affected by pyroglutamylated apelin-13 (Pyr-AP13) remain unclear. "
|1.||Acetic Acid (Vinegar)
|3.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|4.||Messenger RNA (mRNA)
|6.||Caspase 3 (Caspase-3)
|7.||Angiogenesis Inducing Agents (Angiogenesis Factor)
|8.||Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)
|9.||70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)
|2.||Acupuncture Points (Acupuncture Point)